• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

突变型和野生型p53对整体基因表达影响的比较。

Comparison of the effect of mutant and wild-type p53 on global gene expression.

作者信息

O'Farrell Thomas J, Ghosh Paritosh, Dobashi Nobuaki, Sasaki Carl Y, Longo Dan L

机构信息

Laboratory of Immunology, Gerontology Research Center, National Institute on Aging, NIH, Baltimore, Maryland 21224, USA.

出版信息

Cancer Res. 2004 Nov 15;64(22):8199-207. doi: 10.1158/0008-5472.CAN-03-3639.

DOI:10.1158/0008-5472.CAN-03-3639
PMID:15548685
Abstract

The mechanisms for "gain-of-function" phenotypes produced by mutant p53s such as enhanced proliferation, resistance to transforming growth factor-beta-mediated growth suppression, and increased tumorigenesis are not known. One theory is that these phenotypes are caused by novel transcriptional regulatory events acquired by mutant p53s. Another explanation is that these effects are a result of an imbalance of functions caused by the retention of some of the wild-type transcriptional regulatory events in the context of a loss of other counterbalancing activities. An analysis of the ability of DNA-binding domain mutants A138P and R175H, and wild-type p53 to regulate the expression levels of 6.9 x 10(3) genes revealed that the mutants retained only <5% of the regulatory activities of the wild-type protein. A138P p53 exhibited mostly retained wild-type regulatory activities and few acquired novel events. However, R175H p53 possessed an approximately equal number of wild-type regulatory events and novel activities. This is the first report that, after examination of the regulation of a large unfocused set of genes, provides data indicating that remaining wild-type transcriptional regulatory functions existing in the absence of counterbalancing activities as well as acquired novel events both contribute to the gain-of-function phenotypes produced by mutant p53s. However, mutant p53s are likely to be distinct in terms of the extent to which each mechanism contributes to their gain-of-function phenotypes.

摘要

由突变型p53产生的“功能获得性”表型的机制尚不清楚,如增殖增强、对转化生长因子-β介导的生长抑制的抗性以及肿瘤发生增加。一种理论认为,这些表型是由突变型p53获得的新的转录调控事件引起的。另一种解释是,这些效应是由于在其他平衡活动丧失的情况下,一些野生型转录调控事件的保留导致功能失衡的结果。对DNA结合结构域突变体A138P和R175H以及野生型p53调节6.9×10³个基因表达水平能力的分析表明,这些突变体仅保留了野生型蛋白不到5%的调控活性。A138P p53大多保留了野生型调控活性,很少获得新的事件。然而,R175H p53具有数量大致相等的野生型调控事件和新活性。这是第一份报告,在检查了一大组未聚焦的基因的调控后,提供的数据表明,在没有平衡活动的情况下存在的剩余野生型转录调控功能以及获得的新事件都有助于突变型p53产生的功能获得性表型。然而,就每种机制对其功能获得性表型的贡献程度而言,突变型p53可能是不同的。

相似文献

1
Comparison of the effect of mutant and wild-type p53 on global gene expression.突变型和野生型p53对整体基因表达影响的比较。
Cancer Res. 2004 Nov 15;64(22):8199-207. doi: 10.1158/0008-5472.CAN-03-3639.
2
Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes.突变型p53通过阻止野生型p53与其靶基因启动子结合而发挥显性负效应。
Oncogene. 2004 Mar 25;23(13):2330-8. doi: 10.1038/sj.onc.1207396.
3
Lack of correlation between p53-dependent transcriptional activity and the ability to induce apoptosis among 179 mutant p53s.179种突变型p53中,p53依赖的转录活性与诱导细胞凋亡能力之间缺乏相关性。
Cancer Res. 2005 Mar 15;65(6):2108-14. doi: 10.1158/0008-5472.CAN-04-2935.
4
Transcription regulation by mutant p53.突变型p53的转录调控
Oncogene. 2007 Apr 2;26(15):2202-11. doi: 10.1038/sj.onc.1210294.
5
Mutant p53 induces the GEF-H1 oncogene, a guanine nucleotide exchange factor-H1 for RhoA, resulting in accelerated cell proliferation in tumor cells.突变型p53诱导GEF-H1癌基因,即一种针对RhoA的鸟嘌呤核苷酸交换因子H1,导致肿瘤细胞中的细胞增殖加速。
Cancer Res. 2006 Jun 15;66(12):6319-26. doi: 10.1158/0008-5472.CAN-05-4629.
6
Mutant p53 proteins behave in a dominant, negative fashion in vivo.突变型p53蛋白在体内以显性负性方式发挥作用。
Anticancer Res. 1994 Sep-Oct;14(5A):1853-9.
7
Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.突变型人类肿瘤抑制因子p53可调节丝裂原活化蛋白激酶和核因子-κB的激活,但不影响c-Jun氨基末端激酶和活化蛋白-1的激活。
Mol Carcinog. 2006 Jan;45(1):26-37. doi: 10.1002/mc.20149.
8
Localization of a mutant p53 response element on the tissue inhibitor of metalloproteinase-3 promoter: mutant p53 activities are distinct from wild-type.金属蛋白酶组织抑制剂-3启动子上突变型p53反应元件的定位:突变型p53的活性与野生型不同。
Cancer Lett. 2006 Aug 18;240(1):48-59. doi: 10.1016/j.canlet.2005.08.027. Epub 2005 Oct 19.
9
Transcriptional activities of mutant p53: when mutations are more than a loss.突变型p53的转录活性:当突变不止是功能丧失时。
J Cell Biochem. 2004 Nov 15;93(5):878-86. doi: 10.1002/jcb.20271.
10
Mutant p53 gain of function: repression of CD95(Fas/APO-1) gene expression by tumor-associated p53 mutants.突变型p53的功能获得:肿瘤相关p53突变体对CD95(Fas/APO-1)基因表达的抑制作用
Oncogene. 2003 Aug 28;22(36):5667-76. doi: 10.1038/sj.onc.1206724.

引用本文的文献

1
Comparing P53 expression and genome-wide transcriptome profiling to Comet assay in lymphocytes from melanoma patients and healthy controls.比较黑色素瘤患者和健康对照者淋巴细胞中 P53 表达和全基因组转录组谱与彗星试验。
Sci Rep. 2023 Nov 1;13(1):18858. doi: 10.1038/s41598-023-44965-z.
2
Transcriptional mutagenesis dramatically alters genome-wide p53 transactivation landscape.转录诱变显著改变全基因组范围内的 p53 反式激活景观。
Sci Rep. 2020 Aug 11;10(1):13513. doi: 10.1038/s41598-020-70412-4.
3
Cancer and Alzheimer's disease inverse relationship: an age-associated diverging derailment of shared pathways.
癌症与老年痴呆症呈负相关:共享通路在年龄相关的分歧中脱轨。
Mol Psychiatry. 2021 Jan;26(1):280-295. doi: 10.1038/s41380-020-0760-2. Epub 2020 May 7.
4
Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers.突变型p53蛋白与Hippo信号转导分子YAP和TAZ:人类癌症中的关键致癌节点
Int J Mol Sci. 2017 May 3;18(5):961. doi: 10.3390/ijms18050961.
5
Gene Coexpression Analyses Differentiate Networks Associated with Diverse Cancers Harboring TP53 Missense or Null Mutations.基因共表达分析区分与携带TP53错义或无效突变的多种癌症相关的网络。
Front Genet. 2016 Aug 3;7:137. doi: 10.3389/fgene.2016.00137. eCollection 2016.
6
Hepatic stellate cell promoted hepatoma cell invasion via the HGF/c-Met signaling pathway regulated by p53.肝星状细胞通过由p53调节的HGF/c-Met信号通路促进肝癌细胞侵袭。
Cell Cycle. 2016;15(7):886-94. doi: 10.1080/15384101.2016.1152428.
7
Mutation-induced protein interaction kinetics changes affect apoptotic network dynamic properties and facilitate oncogenesis.突变诱导的蛋白质相互作用动力学变化影响凋亡网络动态特性并促进肿瘤发生。
Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):E4046-54. doi: 10.1073/pnas.1502126112. Epub 2015 Jul 13.
8
Comparison of effects of p53 null and gain-of-function mutations on salivary tumors in MMTV-Hras transgenic mice.p53基因缺失和功能获得性突变对MMTV-Hras转基因小鼠唾液腺肿瘤影响的比较。
PLoS One. 2015 Feb 19;10(2):e0118029. doi: 10.1371/journal.pone.0118029. eCollection 2015.
9
Mapping the p53 transcriptome universe using p53 natural polymorphs.利用p53自然多态性绘制p53转录组图谱
Cell Death Differ. 2014 Apr;21(4):521-32. doi: 10.1038/cdd.2013.132. Epub 2013 Sep 27.
10
Polo-like kinase 4 transcription is activated via CRE and NRF1 elements, repressed by DREAM through CDE/CHR sites and deregulated by HPV E7 protein.Polo-like kinase 4 的转录通过 CRE 和 NRF1 元件激活,通过 CDE/CHR 位点被 DREAM 抑制,并被 HPV E7 蛋白失调。
Nucleic Acids Res. 2014 Jan;42(1):163-80. doi: 10.1093/nar/gkt849. Epub 2013 Sep 25.